Screening of Lactose Intolerance Among IBS Patients Diarrhea Dominant
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Lactose Intolerance. Basic parameters: 18 years — 70 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Screening for Lactose Intolerance Among Patients With IBS Diarrhea Dominant
Overview
This cross-sectional study aims to determine the prevalence of lactose intolerance among patients with chronic diarrhea, assess its correlation with age and gender, and evaluate common symptoms in affected patients. The study will collect demographic data, conduct lactose intolerance testing via PCR, and use a symptom questionnaire.
Detailed description
The study is designed as a cross-sectional analysis conducted at a single healthcare center. Its primary objectives are:
To determine the point prevalence of lactose intolerance in patients suffering from chronic diarrhea (lasting more than four weeks).
To explore potential correlations between lactose intolerance and demographic factors such as age and gender.
To identify the most common symptoms associated with lactose intolerance in this patient population.
Methodology:
Data Collection: Demographic information (age, sex, medical history, and diarrhea duration) will be gathered.
Lactose Intolerance Testing: Polymerase Chain Reaction (PCR) will be employed to diagnose lactose intolerance.
Symptom Questionnaire: A standardized questionnaire will be administered to document symptoms like abdominal pain, bloating, flatulence, diarrhea, and nausea.
Primary outcome measures
- Prevalence data on lactose intolerance in patients with IBS diarrhea dominant. [Time frame: 1 year]
Eligibility criteria
Inclusion criteria
- All Patients with IBS diarrhea dominant type meet Rome criteria attending at Al-Rajhy University Hospital during 6 months (from march to September). A patient must have recurrent abdominal pain (at least 1 day per week in the last 3 months) associated with at least two of the following:
- Related to defecation (pain improves or worsens with bowel movements).
- Change in stool frequency (diarrhea or constipation).
- Change in stool form (appearance) (loose, watery, hard, or lumpy).
- Patients aged >18 years.
- Both males and females
Exclusion criteria
- -patient aged<18 years old.
- Patients with chronic diarrhea don't meet Rome criteria
- patients with malignancies
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Other
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06931379 · Screening of lactose intolera